A Study of YL202 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Daiichi Sankyo
ImmunityBio, Inc.
Mayo Clinic
University of Pittsburgh
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
Vall d'Hebron Institute of Oncology
Tasly Biopharmaceuticals Co., Ltd.
Merck Sharp & Dohme LLC
Convalife (Shanghai) Co., Ltd.
Sun Yat-sen University
pharmaand GmbH
Seagen Inc.
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
Roswell Park Cancer Institute
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Hoag Memorial Hospital Presbyterian